Pancreatic Cancer Research

ResearcherMedical College of WisconsinActive in the last 2 years

Ergun E. Ahunbay

ORCID-verified (high confidence, 0.95), identity_conf@1As of 7 November 2026

Matched on ORCID iD 0000-0002-6194-8618; OpenAlex author ID A5042267072. Sources: ClinicalTrials.gov.

Their work

Papers
4
Trials
1 (principal investigator on 1)
Grants
0
Labs led
0
Collaborators
7
Papers, trials and grants by year

2009: 1 trial · 2010: none · 2011: none · 2012: 1 paper · 2013: 1 paper · 2014: none · 2015: none · 2016: none · 2017: none · 2018: none · 2019: none · 2020: 1 paper · 2021: none · 2022: none · 2023: none · 2024: none · 2025: 1 paper

Papers 4

  1. Deep learning-based quick MLC sequencing for MRI-guided online adaptive radiotherapy: a feasibility study for pancreatic cancer patients. Co-author DOI 10.1088/1361-6560/adb099↗
  2. Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI bas… Co-author DOI 10.1371/journal.pone.0236570↗
  3. Comparison of various online strategies to account for interfractional variations for pancreatic cancer. Co-author DOI 10.1016/j.ijrobp.2013.04.032↗
  4. TU-E-BRA-01: A Comparison of Various Online Strategies to Account for Interfractional Variations for Pancreatic Cancer. Co-author DOI 10.1118/1.4735961↗

Trials 1

  1. Advanced MRI Sequences for Radiation Therapy Treatment Planning Principal investigator NCT02340715↗

Closest collaborators

The 7 strongest of 7 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

  1. E.S. Paulson · 2 shared papers, 2020–2025 · strength 0.48
  2. Ying Zhang · 1 shared paper, 2025 · strength 0.37
  3. Ahmet Efe Ahunbay · 1 shared paper, 2025 · strength 0.37
  4. Bradley A. Erickson · 2 shared papers, 2013–2020 · strength 0.16
  5. X. Allen Li · 2 shared papers, 2013–2020 · strength 0.16
  6. William Adrian Hall · 1 shared paper, 2020 · strength 0.11
  7. X Li · 1 shared paper, 2012 · strength 0.04

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.